Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
Hematologic Oncology Update
00:00
Emerging agents: sonrotoclax and pirtobrutinib
Rogers previews sonrotoclax combos (Celestial) and pirtobrutinib data in heavily pretreated CLL, highlighting unmet needs.
Play episode from 08:39
Transcript
